RX ACCULINK CAROTID STENT SYSTEM
Report
- Report Number
- 3004742046-2009-00243
- Event Type
- Injury
- Date Received
- September 21, 2009
- Date of Event
- August 26, 2009
- Report Date
- September 1, 2009
- Manufacturer
- ABBOTT VASCULAR-VASCULAR SOLUTIONS
- Product Code
- NIM
- PMA / PMN Number
- P040038
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE #1, THE RX ACCUNET EMBOLIC PROTECTION DEVICE LOT NUMBER 8021851 IS BEING FILED UNDER MANUFACTURER REPORT NUMBER 3004742046-2009-00242. EVALUATION SUMMARY: THE DEVICE WAS NOT RETURNED. IT IS POSSIBLE THAT THE INACCURATE DELIVERY OF THE STENT MAY BE THE RESULT OF, BUT NOT LIMITED TO, THE VESSEL MORPHOLOGY, THE VESSEL DIAMETER WHICH COULD HAVE BEEN LARGER THAN THE STENT, THE STENT NOT APPOSING THE VESSEL WALL WHEN FULLY DEPLOYED AND/OR INADVERTENT MOVEMENT OF THE HANDLE DURING DEPLOYMENT. FURTHERMORE, AS PER THE RX ACCULINK INSTRUCTIONS FOR USE, SECTION 5.2 STENT PLACEMENT- PRECAUTIONS: "PRIOR TO STENT DEPLOYMENT, REMOVE ALL SLACK FROM THE DELIVERY SYSTEM." BASED ON AVAILABLE INFORMATION, THE HEAVILY TORTUOUS VESSEL COULD HAVE CONTRIBUTED TO THE EVENT. AS PART OF MANUFACTURING QUALITY PROCESS, ALL CATHETERS ARE INSPECTED DURING THE FINAL INSPECTION TO ENSURE THE PRODUCT STRUCTURE AND INTEGRITY. IN ADDITION, SAMPLES FROM EACH LOT ARE VISUALLY, DIMENSIONALLY AND FUNCTIONALLY INSPECTED. HYPOTENSION IS A KNOWN POSSIBLE ADVERSE EVENT ASSOCIATED WITH THE USE OF THE DEVICE, AS LISTED IN THE INSTRUCTIONS FOR USE. A REVIEW OF THE FINISHED DEVICE LOT HISTORY DID NOT REVEAL ANY NON-CONFORMITIES, WHICH COULD HAVE CONTRIBUTED TO THIS EVENT.
DEVICE #2 MALFUNCTION: INACCURATE DELIVERY. SYMPTOMS/AE: PLACEMENT OF A SECOND STENT. TIME OF MALFUNCTION/AE: DURING THE PROCEDURE. IT WAS REPORTED THAT DURING A RIGHT INTERNAL CAROTID ARTERY STENTING PROCEDURE, PLACEMENT OF THE RX ACCUNET WAS DIFFICULT DUE TO THE VESSEL TORTUOSITY. THE BUDDY WIRE TECHNIQUE WAS USED AND THE DEVICE WAS SUCCESSFULLY PLACED. WHILE DEPLOYING THE RX ACCULINK STENT, THE STENT MOVED UPWARD, NOT FULLY COVERING THE TARGET LESION. AN XACT STENT WAS PLACED COVERING THE PROXIMAL LESION; HOWEVER, DURING DEPLOYMENT OF THE XACT STENT, THE PATIENT HAD A SHORT EPISODE OF HYPOTENSION TREATED WITH A BOLUS OF NEOSYNEPHRINE AND EXPERIENCED A STROKE DISPLAYING APHASIA AND FLACCIDITY OF THE RIGHT SIDE. TWO DAYS POST PROCEDURE, AN MRI SHOWED EIGHT SMALL AREAS OF EMBOLIC INFARCTS IN THE BILATERAL FRONTAL, LEFT PARIETAL PRECENTRAL GYRI. THE PATIENT STARTED IMPROVING ALMOST IMMEDIATELY AND FIVE DAYS POST PROCEDURE WAS BACK TO BASELINE AND DISCHARGED TO HOME. ALTHOUGH REQUESTED, THERE WAS NO ADDITIONAL INFORMATION PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | RX ACCULINK CAROTID STENT SYSTEM | NIM | ABBOTT VASCULAR-VASCULAR SOLUTIONS | NA | 9011551 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Required Intervention | MS SHEATH| (DEVICE #1) RX ACCUNET EMBOLIC PROTECTION DEVICE| LOT #8021851| AVANTI| 6F BENTSON HANAFEE WILSON CATHETER| BIVALIRUDIN| STABILIZER XS GUIDEWIRE| 5X20X135| VIATRAC 4X20X135 |